Last reviewed · How we verify
ENO Lime
ENO Lime is an antacid that neutralizes stomach acid to relieve heartburn and indigestion.
ENO Lime is an antacid that neutralizes stomach acid to relieve heartburn and indigestion. Used for Heartburn and acid indigestion relief.
At a glance
| Generic name | ENO Lime |
|---|---|
| Sponsor | HALEON |
| Drug class | Antacid |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology |
| Phase | Phase 3 |
Mechanism of action
ENO Lime contains sodium bicarbonate and other alkaline salts that react with gastric acid to form neutral salts and carbon dioxide, thereby raising gastric pH and providing rapid symptomatic relief of acid-related discomfort. The effervescent formulation enhances palatability and rapid dissolution for quick onset of action.
Approved indications
- Heartburn and acid indigestion relief
Common side effects
- Alkalosis (with chronic use)
- Nausea
- Belching
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ENO Lime CI brief — competitive landscape report
- ENO Lime updates RSS · CI watch RSS
- HALEON portfolio CI